产品封面图

Anti-Human FZD3/Frizzled-3 Nan

obody (SAA2318)
收藏
  • ¥1668
  • abinScience
  • China
  • HC066013
  • 2025年07月25日
  • ELISA
  • Human
  • Human
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      Human

    • 亚型

      VHH-Fc

    • 形态

      Liquid

    • 保存条件

      0.01M PBS pH 7.4

    • 克隆性

      Monoclonal

    • 标记物

      Unconjugated

    • 适应物种

      Human

    • 保质期

      1 year

    • 抗原来源

      Human

    • 目录编号

      HC066013

    • 级别

      科研级别

    • 库存

      999

    • 供应商

      abinScience

    • 宿主

      Human

    • 应用范围

      ELISA

    • 浓度

      1mg/mL

    • 靶点

      Frizzled-3, Fz-3, hFz3, FZD3

    • 抗体英文名

      Anti-Human FZD3/Frizzled-3 Nanobody (SAA2318)

    • 抗体名

      Anti-Human FZD3/Frizzled-3 Nanobody (SAA2318)

    • 规格

      100ul

    产品细节图片1

    Product nameAnti-Human FZD3/Frizzled-3 Nanobody (SAA2318)
    Catalog No.HC066013
    Host speciesHuman
    Species reactivityHuman
    Immunogen/
    FormLiquid
    Storage buffer0.01M PBS pH 7.4
    Purity>95% as determined by SDS-PAGE.
    ClonalityMonoclonal
    IsotypeVHH-Fc
    ApplicationsELISA
    TargetFrizzled-3, Fz-3, hFz3, FZD3
    PurificationProtein A/G purified from cell culture supernatant.
    Endotoxin levelPlease contact with the lab for this information.
    Expression system/
    AccessionQ9NPG1
    Alternative Names/
    Clone IDSAA2318
    Species/
    Product Usage Information/

    abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.

     

    Technology and Innovation

    Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.

     

    Product categories and application fields.

    Main products.
    10000+ high-activity proteins.
    15000+ antibody series products:
    Classic monoclonal antibody.
    Monoclonal antibody
    Internal control antibody, labeled antibody.
    High-quality phosphorylation antibodies.
    Highly specific nanobodies and small molecule antibodies.
    Functional antibodies in vivo.
    Low-background flow cytometry antibodies.
    DNA/RNA antibodies and PEG antibodies.
    1000+ reagent kit series products.
    Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.


    Application field

    Infectious disease research: including viruses, superbugs, parasites, etc.
    Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
    Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
    Oncology research: Supporting the development of tumor biology and anti-tumor drugs.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • v468.Chapter 3 分泌型跨膜相关蛋白提纯及Wnt抑制活性

      ., Vukicevic, S., and Luyten, F.P. (1996) Primary structure and tissue distribution of Frzb, a novel protein related to Drosophila frizzled, suggest a role in human skeletal morphogenesis. J. Biol. Chem . 271 , 26131–26137. 6. Finch, P.W., He., X., Kelley, M

    • 您所不知道的Treg——“NAD+诱导细胞凋亡”途径

      凋亡”途径,使得从小鼠中获取较多数量的活性细胞比较困难,也成为这类研究的桎梏。 为此,研发人员推出了Treg-ProtectorTM(anti-ARTC Nanobody)产品,该纳米抗体能够有效抑制NAD+与 ARTC2的结合,从而抑制因损伤等刺激性条件引起NAD+诱导的细胞凋亡途径,从而提高活性细胞的数量。研究结果表明,将这种纳米抗体注射到小鼠体内能有助于收集活性Treg细胞的数量,就像获取NK细胞的方法一样, 实验结果可以观察到注射了Treg-ProtectorTM小鼠的脾脏细胞中Treg的细胞

    • Background Information of RNAi

      group who were expressing genes from the potato virus X in tobacco plants, hoped that viral proteins produced by the plants would stimulate a defense mechanism allowing the plants to resist subsequent attack by the virus. To their surprise, the plants

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥993
    广州市左克生物科技发展有限公司
    2025年09月02日询价
    ¥1668
    普健生物(武汉)科技有限公司
    2025年07月25日询价
    $495
    安诺伦(北京)生物科技有限公司
    2025年05月20日询价
    询价
    卡梅德生物科技(天津)有限公司
    2025年10月21日询价
    Anti-Human FZD3/Frizzled-3 Nanobody (SAA2318)
    ¥1668